Literature DB >> 20845284

Diffuse plexiform neurofibroma of the back: report of a case.

Ezella N Washington1, Timothy P Placket, Ronald A Gagliano, Jeffery Kavolius, Donald A Person.   

Abstract

Neurofibromatosis type 1 is an autosomal dominant disorder affecting the ras proto-oncogene. It is characterized by the overgrowth of nervous tissue and skin discoloration. While it is associated with a variety of phenotypic presentations, it is the plexiform variant that is particular concerning, as it can become extremely disfiguring and has a propensity for malignant degeneration. A case of a Pacific Islander with a large plexiform type 1 neurofibroma is presented. The patient was ultimately treated with surgical resection, negative pressure wound therapy, and split-thickness skin grafting with good results. A review of the literature concerning the diagnosis and treatment of neurofibromatosis is included. Hawaii Medical Journal Copyright 2010.

Entities:  

Mesh:

Year:  2010        PMID: 20845284      PMCID: PMC3118022     

Source DB:  PubMed          Journal:  Hawaii Med J        ISSN: 0017-8594


  19 in total

Review 1.  Recent insights into neurofibromatosis type 1: clear genetic progress.

Authors:  D H Gutmann
Journal:  Arch Neurol       Date:  1998-06

2.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

3.  Phase II trial of pirfenidone in adults with neurofibromatosis type 1.

Authors:  D Babovic-Vuksanovic; K Ballman; V Michels; P McGrann; N Lindor; B King; J Camp; V Micic; N Babovic; X Carrero; R Spinner; B O'Neill
Journal:  Neurology       Date:  2006-10-11       Impact factor: 9.910

4.  Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994.

Authors:  M N Needle; A Cnaan; J Dattilo; J Chatten; P C Phillips; S Shochat; L N Sutton; S N Vaughan; E H Zackai; H Zhao; P T Molloy
Journal:  J Pediatr       Date:  1997-11       Impact factor: 4.406

Review 5.  Malignancy in neurofibromatosis type 1.

Authors:  B R Korf
Journal:  Oncologist       Date:  2000

Review 6.  Peripheral nerve tumors: management strategies and molecular insights.

Authors:  Asis Kumar Bhattacharyya; Richard Perrin; Abhijit Guha
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

7.  Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1.

Authors:  Andrea Ferrari; Gianni Bisogno; Alessandra Macaluso; Michela Casanova; Paolo D'Angelo; Paolo Pierani; Ilaria Zanetti; Rita Alaggio; Giovanni Cecchetto; Modesto Carli
Journal:  Cancer       Date:  2007-04-01       Impact factor: 6.860

8.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Authors:  D F Easton; M A Ponder; S M Huson; B A Ponder
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

9.  Massive plexiform neurofibromas in childhood: natural history and management issues.

Authors:  Demitre Serletis; Patricia Parkin; Eric Bouffet; Manohar Shroff; James M Drake; James T Rutka
Journal:  J Neurosurg       Date:  2007-05       Impact factor: 5.115

10.  Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas.

Authors:  Dusica Babovic-Vuksanovic; Brigitte C Widemann; Eva Dombi; Andrea Gillespie; Pamela L Wolters; Mary Anne Toledo-Tamula; Brian P O'Neill; Elizabeth Fox; Tobey MacDonald; Heather Beck; Roger J Packer
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

View more
  6 in total

1.  Retroperitoneal Malignant Peripheral Nerve Sheath Tumour: A Rare Case Report.

Authors:  Ayse Nur Deger; Mehmet Akif Bayar; Muzaffer Caydere; Hakki Deger; Mahir Tayfur
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.

Authors:  Kellie B Haworth; Michael A Arnold; Christopher R Pierson; Kwangmin Choi; Nicholas D Yeager; Nancy Ratner; Ryan D Roberts; Jonathan L Finlay; Timothy P Cripe
Journal:  Oncotarget       Date:  2017-05-30

3.  Successful treatment by negative-pressure wound therapy for ulcer located on diffuse plexiform neurofibroma.

Authors:  Hiroko Sekiyama; Yoshimasa Nobeyama; Hidemi Nakagawa
Journal:  J Dermatol       Date:  2017-07-22       Impact factor: 4.005

4.  Massive Plexiform Neurofibroma of the Neck and Larynx.

Authors:  Mohammad Kamal Mobashir; Abd ElRaof Said Mohamed; Mohammad Waheed El-Anwar; Ahmad Ebrahim El Sayed; Mouhamad A Fouad
Journal:  Int Arch Otorhinolaryngol       Date:  2014-12-12

Review 5.  Differential diagnoses of overgrowth syndromes: the most important clinical and radiological disease manifestations.

Authors:  Letícia da Silva Lacerda; Ursula David Alves; José Fernando Cardona Zanier; Dequitier Carvalho Machado; Gustavo Bittencourt Camilo; Agnaldo José Lopes
Journal:  Radiol Res Pract       Date:  2014-06-09

6.  Klippel-Trenaunay Syndrome with Extensive Lymphangiomas.

Authors:  Sirin Mneimneh; Ali Tabaja; Mariam Rajab
Journal:  Case Rep Pediatr       Date:  2015-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.